06/11/2025
An encouraging new study by Public Health Scotland, in collaboration with the The University of Edinburgh and University of Strathclyde, confirms the human papillomavirus (HPV) vaccine provides strong and sustained protection against cervical disease that can develop into cancer.
Data from the study, published in International Journal of Cancer today, show that the HPV vaccine provides protection when administered to girls aged 18 years or less, with the greatest benefits seen in girls vaccinated at age 12-13.
Previous studies have shown that the HPV vaccine is highly effective in preventing the development of cervical pre-cancer and cancer. This study using population health data, shows that the vaccine continues to be effective more than 12 years after it was given, in women who came forward for cervical screening.
Dr Kirsty Roy, Consultant in Public Health, Public Health Scotland said:
“Vaccination against HPV is effective in preventing cervical cancer and, along with regular screening for early detection and treatment, it is possible to make cervical cancer a rare disease.”
Read more on our website⬇️
https://publichealthscotland.scot/news/2025/november/new-study-shows-long-term-effectiveness-of-hpv-vaccine/